Sangamo Therapeutics (SGMO)
0.18
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 8-K SANGAMO THERAPEUTICS, For: Jun 24
July 1, 2026 4:01 PM - SEC Filing
Form 8-K/A SANGAMO THERAPEUTICS, For: Jun 18
June 23, 2026 4:42 PM - SEC Filing
Form 8-K SANGAMO THERAPEUTICS, For: Jun 18
June 23, 2026 8:46 AM - SEC Filing
Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas
June 23, 2026 8:05 AM - StreetInsider
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
June 23, 2026 8:05 AM - Globe NewsWire
Sangamo Therapeutics explores strategic alternatives with Raymond James
June 8, 2026 8:06 AM - StreetInsider
Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders
June 8, 2026 8:05 AM - Globe NewsWire
Form 4 SANGAMO THERAPEUTICS, For: May 25 Filed by: Jain Nikunj
May 27, 2026 7:30 PM - SEC Filing
Form 4 SANGAMO THERAPEUTICS, For: May 25 Filed by: Dubois-Stringfellow Nathalie
May 27, 2026 7:30 PM - SEC Filing
Form 4 SANGAMO THERAPEUTICS, For: May 25 Filed by: Davis Gregory D
May 27, 2026 7:30 PM - SEC Filing
Form 4 SANGAMO THERAPEUTICS, For: May 25 Filed by: Macrae Sandy
May 27, 2026 7:30 PM - SEC Filing
Form 4 SANGAMO THERAPEUTICS, For: May 25 Filed by: Willoughby Scott B.
May 27, 2026 7:30 PM - SEC Filing
Sangamo BioSciences (SGMO) PT Lowered to $5 at H.C. Wainwright
May 26, 2026 11:44 AM - StreetInsider
Form SCHEDULE 13G SANGAMO THERAPEUTICS, Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:27 AM - SEC Filing
Form 10-Q SANGAMO THERAPEUTICS, For: Mar 31
May 14, 2026 4:05 PM - SEC Filing
Form 8-K SANGAMO THERAPEUTICS, For: May 14
May 14, 2026 4:03 PM - SEC Filing
Sangamo Therapeutics (SGMO) Misses Q1 EPS by 2c
May 14, 2026 4:03 PM - StreetInsider
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results
May 14, 2026 4:01 PM - Globe NewsWire
Full Article List
